Carl Zeiss Meditec AG
CZMWY
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.17B
Close$
Share Statistics
| Market cap | $3.17 Billion |
|---|---|
| Enterprise Value | $3.17 Billion |
| Dividend Yield | $0.63 (1.70%) |
| Earnings per Share | $1.52 |
| Beta | 1.46 |
| Outstanding Shares | 86,302,842 |
Return
| Return on Equity | 5.54% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 19.41 |
|---|---|
| PEG | 20.67 |
| Price to Sales | 1.21 |
| Price to Book Ratio | 1.51 |
| Enterprise Value to Revenue | 1.19 |
| Enterprise Value to EBIT | 13.16 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
December 10, 2026
EPS Estimate
$1.38
Average shareholder expectationRevenue Estimate
$1.07 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Carl Zeiss Meditec AG
5,784 employees
CEO: Andreas Pecher Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for ...